{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:49:11Z","timestamp":1791305351933,"version":"4.3.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":4144,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1600-6143.2011.03637.x","type":"journal-article","created":{"date-parts":[[2011,7,28]],"date-time":"2011-07-28T19:51:34Z","timestamp":1311882694000},"page":"1665-1675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF\u2014Four-Year Results of the Postconcept Study"],"prefix":"10.1016","volume":"11","author":[{"given":"Y.","family":"Lebranchu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Thierry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Thervet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"B\u00fcchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Etienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.F.","family":"Westeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Hurault","family":"de Ligny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"R\u00e9rolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Frouget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Girardot-Seguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Toupance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2011.03637.x_bib1","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1600-6143.2004.00332.x","article-title":"Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era","volume":"4","author":"Meier-Kriesche","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.TP.0000128636.70499.6E","article-title":"Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology","volume":"78","author":"Nankivell","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib3","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/00007890-200004150-00009","article-title":"Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients","volume":"69","author":"Kreis","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib4","first-page":"1036","article-title":"Sirolimus (rapamycin)-based therapy in human renal transplantation: Similar efficacy and different toxicity compared with cyclosporine","volume":"67","author":"Groth","year":"1999","journal-title":"Sirolimus European Renal Transplant Study Group. Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib5","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/j.1600-6143.2004.00627.x","article-title":"De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years","volume":"4","author":"Flechner","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib6","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1111\/j.1600-6143.2007.01976.x","article-title":"Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids","volume":"7","author":"Buchler","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00007890-200109150-00007","article-title":"Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure","volume":"72","author":"Johnson","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib8","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1097\/00007890-200212150-00013","article-title":"Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination","volume":"74","author":"Gonwa","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1432-2277.2004.00052.x","article-title":"Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation","volume":"18","author":"Oberbauer","year":"2005","journal-title":"Transpl Int"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib10","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1016\/j.transproceed.2009.05.009","article-title":"Similar lipid profile but improved long-term outcomes with sirolimus after cyclosporine withdrawal compared to sirolimus with continuous cyclosporine","volume":"41","author":"Morales","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib11","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1600-6143.2009.02615.x","article-title":"Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: Concept study","volume":"9","author":"Lebranchu","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1523-1755.2002.00424.x","article-title":"Post-transplant renal function in the first year predicts long-term kidney transplant survival","volume":"62","author":"Hariharan","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib13","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.transproceed.2009.02.075","article-title":"Chronic renal disease in renal transplant patients: Management of cardiovascular risk factors","volume":"41","author":"Fernandez-Fresnedo","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib14","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/01.tp.0000184623.35773.6a","article-title":"Conversion from cyclosporine to sirolimus in stable renal transplant recipients","volume":"80","author":"Sennesael","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/TP.0b013e3181927a41","article-title":"Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the convert trial","volume":"87","author":"Schena","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib16","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/j.1600-6143.2005.01055.x","article-title":"A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal transplantation","volume":"5","author":"Watson","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/TP.0b013e3181e11798","article-title":"Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: One-year analysis of a randomized multicenter trial","volume":"90","author":"Guba","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib18","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/01.tp.0000237101.58974.43","article-title":"Conversion from calcineurin inhibitors to sirolimus for chronic renal allograft dysfunction: A systematic review of the evidence","volume":"82","author":"Mulay","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib19","first-page":"194","article-title":"Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: A randomised multicentre study","volume":"356","author":"Kahan","year":"2000","journal-title":"The Rapamune US Study Group. Lancet"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib20","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1600-6143.2009.02726.x","article-title":"Calcineurin inhibitor minimization in the symphony study: Observational results 3 years after transplantation","volume":"9","author":"Ekberg","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib21","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1600-6143.2010.03016.x","article-title":"A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (benefit-ext study)","volume":"10","author":"Durrbach","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (benefit study)","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib23","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1097\/TP.0b013e3181a76823","article-title":"Cyclosporine withdrawal improves long-term graft survival in renal transplantation","volume":"87","author":"Gallagher","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib24","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1600-6143.2006.01645.x","article-title":"Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: The Caesar study","volume":"7","author":"Ekberg","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib25","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1681\/ASN.2005030312","article-title":"Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: Results from a prospective, randomized trial","volume":"16","author":"Hazzan","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib26","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1097\/00007890-200212270-00015","article-title":"Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen in stable kidney transplant recipients: A randomized, controlled study","volume":"74","author":"Abramowicz","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib27","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1681\/ASN.2004100844","article-title":"Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: Results of a five-year, prospective, randomized study","volume":"16","author":"Abramowicz","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib28","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.tp.0000258586.52777.4c","article-title":"Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs","volume":"83","author":"Flechner","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib29","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1681\/ASN.2005060635","article-title":"Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients","volume":"16","author":"Stallone","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 1","key":"10.1111\/j.1600-6143.2011.03637.x_bib30","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1399-0039.2006.00765.x","article-title":"14th International HLA and immunogenetics workshop: Report on the prospective chronic rejection project","volume":"69","author":"Ozawa","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1034\/j.1600-6143.2002.020204.x","article-title":"Clinical significance of MHC-reactive alloantibodies that develop after kidney or kidney-pancreas transplantation","volume":"2","author":"Pelletier","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib32","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1681\/ASN.2007010073","article-title":"Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis","volume":"18","author":"Colvin","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1523-1755.2000.00816.x","article-title":"Long-term survival in renal transplant recipients with graft function","volume":"57","author":"Ojo","year":"2000","journal-title":"Kidney Int."},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib34","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1016\/S0002-8703(99)70311-X","article-title":"Historic perspectives on the relative contributions of diastolic and systolic blood pressure elevation to cardiovascular risk profile","volume":"138","author":"William","year":"1999","journal-title":"American heart journal"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0b013e3181c518cc","article-title":"Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis","volume":"89","author":"Knight","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib36","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1432-2277.2008.00640.x","article-title":"Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation","volume":"21","author":"Roland","year":"2008","journal-title":"Transpl Int"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib37","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1600-6143.2003.00010.x","article-title":"Diabetes mellitus after kidney transplantation in the United States","volume":"3","author":"Kasiske","year":"2003","journal-title":"Am J Transplant"},{"issue":"Suppl 1","key":"10.1111\/j.1600-6143.2011.03637.x_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00003495-200868001-00003","article-title":"Malignancy in kidney transplant recipients","volume":"68","author":"Kapoor","year":"2008","journal-title":"Drugs"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib39","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa042831","article-title":"Sirolimus for kaposi\u2019s sarcoma in renal-transplant recipients","volume":"352","author":"Stallone","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib40","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1399-0012.2004.00188.x","article-title":"Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: Results from five multicenter studies","volume":"18","author":"Mathew","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib41","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1600-6143.2009.02997.x","article-title":"Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: Reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial","volume":"10","author":"Salgo","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib42","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1681\/ASN.2005090993","article-title":"Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation","volume":"17","author":"Campistol","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 2","key":"10.1111\/j.1600-6143.2011.03637.x_bib43","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.2215\/CJN.03040707","article-title":"Late kidney allograft loss: What we know about it, and what we can do about it","volume":"3","author":"Jevnikar","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib44","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1111\/j.1600-6143.2005.01020.x","article-title":"Early low-grade proteinuria: Causes, short-term evolution and long-term consequences in renal transplantation","volume":"5","author":"Halimi","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03637.x_bib45","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1111\/j.1600-6143.2004.00590.x","article-title":"Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction","volume":"4","author":"Diekmann","year":"2004","journal-title":"Am J Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2011.03637.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522280447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522280447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2011.03637.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:54:06Z","timestamp":1761627246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522280447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S1600613522280447"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03637.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF\u2014Four-Year Results of the Postconcept Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03637.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}